Search
Longeveron Inc
LGVNAdd to Watchlist
0.729USD
+0.026+3.71%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
22.44MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
By BusinessUSD
Name
Revenue
Proportion
Clinical trial revenue
954.00K
79.57%
Contract manufacturing
222.00K
18.52%
Contract manufacturing lease revenue
23.00K
1.92%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Clinical trial revenue
954.00K
79.57%
Contract manufacturing
222.00K
18.52%
Contract manufacturing lease revenue
23.00K
1.92%